Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Doctor’s advice for cancer patients: Personal values influence treatment recommendations

03.06.2013
Not only medical aspects influence treatment recommendations
Patients’ desire for participation changes over the course of the disease
What treatment a doctor recommends for advanced cancer not only depends on medical aspects. His relationship to the individual patients and his own view of their life situation at their age play a role. This was found out by a research team led by Dr. Jan Schildmann of the Ruhr-Universität Bochum (RUB) together with colleagues from the University of Oxford. The RUB researchers also explored how patients perceive and evaluate the information they receive for clarification and decision making. The medical ethicists report in the journals “The Oncologist” and “Annals of Oncology”.

One of the most difficult challenges in medicine

“Treatment decisions in advanced, life-threatening diseases are among the most difficult challenges in medicine”, says Jan Schildmann, head of the North Rhine-Westphalian junior research group “Medical Ethics at the End of Life: Norm and Empiricism”. Often scientific data on the benefits and harm of therapies in such situations is scarce. At the RUB Institute for Medical Ethics and History of Medicine, headed by Prof. Dr. Dr. Jochen Vollmann, the scientists investigated how the cancer patients evaluated the explanation of potential therapies and what criteria the doctors based their decisions on. To this end, the researchers interviewed physicians working in medical oncology and cancer patients, and qualitatively evaluated the discussions.

Personal values influence treatment recommendations of doctors
When making decisions for or against a therapy, in addition to medical factors, the age and life situation of patients played a role – for example, whether they had a family. Thus, one of the doctors participating in the interview study said: “I think instinctively you feel that this is a young patient with a young family you need to make even more effort to try and help them live for a bit longer.” The doctors also made comparisons to their own age and their own life situation. “I most recently had a young woman ... with teenage daughters, the same age as my daughters, so there was a kind of sense of ... it shouldn’t influence, but you can picture the person the same as yourself”, as an example from one of the interviews. The results of the studies carried out in England are consistent with previously published results from Germany.

The wishes of the patients change over the course of the disease

In order to explore the wishes of the patients, the researchers interviewed people suffering from pancreatic cancer. The result: at the start of treatment, patients hardly processed the information they received; their confidence in the doctor was crucial. “I placed my life and my illness in the hands of the specialists and said you will do this right”, one of the participants explained. In the course of the disease, however, the people learned to process the doctors’ words better; then they wanted more information and to be involved in the decision on possible therapies.

Reflecting value judgements

“The results of this qualitative study cannot be applied to the entire cohort of oncologists, or all patients with cancer”, says Jan Schildmann. However, results of other research groups have also pointed out that doctors’ treatment recommendations are based not purely on medical aspects. “Doctors should reflect on the value judgments that play a role in the recommendations. They should also consider what information really enables patients to participate in decision-making according to their wishes at a certain time.”

Funding

The empirical study is part of a clinical-ethical research project carried out by the North Rhine-Westphalian junior research group “Medical Ethics at the End of Life: Norm and Empiricism”, funded by the Ministry of Innovation, Science, Research and Technology.

Bibliographic records

J. Schildmann J, P. Ritter, S. Salloch, W. Uhl, J Vollmann (2013): ‘One also needs a bit of trust in the doctor … ’: a qualitative interview study with pancreatic cancer patients about their perceptions and views on information and treatment decision-making, Annals of Oncology, doi: 10.1093/annonc/mdt193

J. Schildmann, J. Tan, S. Salloch, J. Vollmann (2012): “Well, I think there is great variation …”: a qualitative study of oncologists' experiences and views regarding medical criteria and other factors relevant to treatment decisions in advanced cancer, The Oncologist, doi: 10.1634/theoncologist.2012-0206

Further information

PD Dr. med. Jan Schildmann, M.A., Institute for Medical Ethics and History of Medicine, Ruhr-Universität Bochum, Malakowturm, Markstr. 258a, 44799 Bochum, Germany, Tel. +49/234/32-28654, E-mail: jan.schildmann@rub.de

Click for more

Institute for Medical Ethics
http://www.ruhr-uni-bochum.de/malakow/index_en.html

Editor: Dr. Julia Weiler

Dr. Josef König | idw
Further information:
http://www.ruhr-uni-bochum.de/malakow/index_en.html

More articles from Studies and Analyses:

nachricht Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT

nachricht Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Closing the carbon loop

08.12.2016 | Life Sciences

Applicability of dynamic facilitation theory to binary hard disk systems

08.12.2016 | Physics and Astronomy

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>